Literature DB >> 11805174

Variation in the renin angiotensin system throughout the normal menstrual cycle.

Mala Chidambaram1, John A Duncan1, Vesta S Lai1, Daniel C Cattran1, John S Floras1, James W Scholey1, Judith A Miller1.   

Abstract

It has been demonstrated elsewhere that circulating renin angiotensin system (RAS) components peak when plasma estrogen levels are highest, during the luteal phase of the normal menstrual cycle. This phenomenon has been attributed to "activation" of the RAS. The end-organ vasoconstrictive response to this phenomenon has not been well established. In two related experiments, the RAS was studied in healthy, premenopausal women during predefined phases of the normal menstrual cycle. In the first experiment, the circulating components of the RAS and the systemic hemodynamic response to incremental lower body negative pressure (LBNP) during the follicular and luteal phases of the menstrual cycle were examined. Response variables included mean arterial pressure (MAP), renin, plasma renin activity (PRA), angiotensin II (AngII), and aldosterone. Baseline levels of renin, PRA, and aldosterone were significantly higher in the luteal phase. In response to LBNP, there were significant increases in all variables in both phases; however, the humoral response to this stimulus was significantly augmented in the luteal phase compared with the follicular phase. Despite these elevations in circulating components of the RAS during the luteal phase, subjects were unable to maintain MAP in response to LBNP, exhibiting a dramatic depressor response that did not occur during the follicular phase. In the second experiment, renal and peripheral hemodynamic function at baseline, and in response to AngII blockade with losartan, were examined in women during these high and low estrogen phases of the menstrual cycle. The renal and peripheral hemodynamic responses were similar in the luteal phase and the follicular phase. These results demonstrate that, despite an increase in circulating RAS components during the luteal phase of the menstrual cycle, the system is blunted rather than "activated," at least at a tissue level. Further studies are needed to clarify this mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805174     DOI: 10.1681/ASN.V132446

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

1.  Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Tiffany B VanGundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

2.  Phase of the menstrual cycle does not affect orthostatic tolerance in healthy women.

Authors:  Victoria Elizabeth Claydon; Nabeela Raheena Younis; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2006-04       Impact factor: 4.435

3.  Estrogen Receptor α Is Required for Maintaining Baseline Renin Expression.

Authors:  Ko-Ting Lu; Henry L Keen; Eric T Weatherford; Maria Luisa S Sequeira-Lopez; R Ariel Gomez; Curt D Sigmund
Journal:  Hypertension       Date:  2016-02-29       Impact factor: 10.190

4.  Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Authors:  Vicente E Torres; Arlene B Chapman; Ronald D Perrone; K Ty Bae; Kaleab Z Abebe; James E Bost; Dana C Miskulin; Theodore I Steinman; William E Braun; Franz T Winklhofer; Marie C Hogan; Frederic R Oskoui; Cass Kelleher; Amirali Masoumi; James Glockner; Neil J Halin; Diego R Martin; Erick Remer; Nayana Patel; Ivan Pedrosa; Louis H Wetzel; Paul A Thompson; J Philip Miller; Catherine M Meyers; Robert W Schrier
Journal:  Kidney Int       Date:  2011-12-28       Impact factor: 10.612

5.  Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Genevieve Boulet; Leif E Lovblom; Omar N Alhuzaim; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-02-02       Impact factor: 19.112

6.  17alpha-hydroxylase deficiency : biochemical and molecular findings in two sisters and their family.

Authors:  Maria S Perez; Haydee Benencia; Gustavo D Frechtel; Eduardo O Esteban; Maria Christina Gil; Héctor M Targovnik; Norma B Marquez
Journal:  Mol Diagn       Date:  2004

Review 7.  The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.

Authors:  Sebastian Kummer; Gero von Gersdorff; Markus J Kemper; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

8.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Intake of selected minerals and risk of premenstrual syndrome.

Authors:  Patricia O Chocano-Bedoya; Joann E Manson; Susan E Hankinson; Susan R Johnson; Lisa Chasan-Taber; Alayne G Ronnenberg; Carol Bigelow; Elizabeth R Bertone-Johnson
Journal:  Am J Epidemiol       Date:  2013-02-26       Impact factor: 4.897

10.  Sex Differences in Renal Proximal Tubular Cell Homeostasis.

Authors:  Thomas Seppi; Sinikka Prajczer; Maria-Magdalena Dörler; Oliver Eiter; Daniel Hekl; Meinhard Nevinny-Stickel; Iraida Skvortsova; Gerhard Gstraunthaler; Peter Lukas; Judith Lechner
Journal:  J Am Soc Nephrol       Date:  2016-04-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.